SEARCH

SEARCH BY CITATION

References

  • 1
    Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002; 20: 3628-3636.
  • 2
    Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of The AJCC Cancer staging manual. CA Cancer J Clin. 2006; 56: 37-47.
  • 3
    Sacre RA. Clinical evaluation of axillary lymph nodes compared to surgical and pathological findings. Eur J Surg Oncol. 1986; 12: 169-173.
  • 4
    Pamilo M, Soiva M, Lavast EM. Real-time ultrasound, axillary mammography, and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer. J Ultrasound Med. 1989; 8: 115-120.
  • 5
    De Freitas R, Costa MV, Schneider SV, Nicolau MA, Marussi E. Accuracy of ultrasound and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer. Eur J Surg Oncol. 1991; 17: 240-244.
  • 6
    Bombardieri E, Crippa F, Baio SM, Peeters BAM, Pauwels EK. Nuclear medicine advances in imaging of breast cancer. Tumor. 2001; 87: 277-289.
  • 7
    Schillaci O, Scopinaro F, Spanu A, et al. Detection of axillary lymph node metastases in breast cancer with 99mTc-tetrotosniua scintigraphy. Int J Oncol. 2002; 20: 483-487.
  • 8
    Ohta M, Tokuda Y, Saitoh Y, et al. Comparative efficacy of position emission tomography and ultrasonography in preoperative evaluation of axillary lymph node metastases in breast cancer. Breast Cancer. 2000; 7: 99-103.
  • 9
    Murray AD, Staff RT, Redpath TW, et al. Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of nodes. Br J Radiol. 2002; 75: 220-228.
  • 10
    Chae BJ, Bae JS, Kang BJ, Kim SH, Jung SS, Song BJ. Positron emission tomography. Computed tomography in the detection of axillary lymph node metastasis in patients with early stage breast cancer. Jpn J Clin Oncol. 2009; 39: 284-289.
  • 11
    Bonnema J, van Geel AN, van Ooijen B, et al. Ultrasound guided aspiration biopsy for detection of axillary node metastases in breast cancer patients: new diagnostic method. World J Surg. 1997; 21: 270-274.
  • 12
    Krishnamurthy S, Sneige N, Bedi DG, et al. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma, Cancer. 2002; 95: 982-988.
  • 13
    De Kanter AY, van Eijck CH, van Geel AN, et al. Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer. Br J Surg. 1999; 86: 1459-1462.
  • 14
    Yang WT, Ahuja A, Tang A, Suen M, King W, Metreweli C. High resolution sonographic detection of axillary node metastases in breast cancer. J Ultrasound Med. 1996; 16: 241-246.
  • 15
    Vaidya JS, Vyas JJ, Khandelwal KC, Mittra I, Thakur MH. Role of ultrasonography to detect axillary node involvement in operable breast cancer. Eur J Surg Oncol. 1996; 22: 140-143.
  • 16
    Mustonen P, Farin P, Kosunen O, et al. Ultrasonographic detection of metastatic axillary lymph nodes in breast cancer. Ann Chir Gynaecol. 1990; 79: 15-18.
  • 17
    Verbanck J, Vandewiele I, De Winter H, Tytgat J, Van Aelst F, Thanghe W. Value of axillary ultrasonography and sonographically guided puncture of axillary nodes: a prospective study in 144 consecutive patients. J Clin Ultrasound. 1997; 25: 53-56.
  • 18
    Deurloo EE, Tanis PJ, Gilhuijs KG, et al. Reduction in number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer. 2003; 39: 1068-1073.
  • 19
    Sapino A, Cassoni P, Zanon E, et al. Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management. Br J Cancer. 2003; 88: 702-706.
  • 20
    Kuenen-Boumeester V, Menke-Pluymers M, de Kanter AY, Obdeijn IM, Urich D, Van Der Kwast TH. Ultrasound-guided fine needle aspiration cytology of axillary lymph nodes in breast cancer patients. A preoperative staging procedure. Eur J Cancer. 2003; 39: 170-174.
  • 21
    Tate JJT, Lewis V, Archer T, Guyer PG, Royle GT, Taylor I. Ultrasound detection of axillary lymph node metastases in breast cancer. Eur J Surg Oncol. 1989; 15: 139-141.
  • 22
    Feu J, Tresserra F, Fábregas R, et al. Metastatic breast carcinoma in axillary lymph nodes: in vitro US detection. Radiology. 1997; 205: 831-835.
  • 23
    Bedi DG, Krishnamurthy R, Krishnamurthy S, et al. Cortical morphological features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study. AJR Am J Roentgenol. 2008; 191: 646-652.
  • 24
    Alvarez S, Añorbe E, Alcorta P, López F, Alonso I, Cortés J. Role of sonography in the diagnosis of ancillary lymph node metastases in breast cancer: a systematic review. AJR Am J Roentgenol. 2006; 186: 1342-1348.
  • 25
    Jain A, Haisfield-Wolfe ME, Lange J, et al. The role of ultrasound-guided fine-needle aspiration of axillary lymph nodes in the staging of breast cancer. Ann Surg Oncol. 2007; 15: 462-471.
  • 26
    Nori J, Varzi E, Bazzocchi M, et al. Role of axillary lymph node ultrasound and large core biopsy in the preoperative assessment of patients selected for sentinel node biopsy. Radiol Med. 2005; 109: 330-344.
  • 27
    Abe H, Schmidt RA, Sennett CA, et al. US-guided core needle biopsy of axillary lymph nodes in patients with breast cancer: why and how to do it. Radiographics. 2007; 27( suppl 1): S91-S99.
  • 28
    Rao R, Lilley L, Andrews V, Radford L, Ulisscy M. Axillary staging by percutaneous biopsy: sensitivity of fine-needle aspiration versus needle biopsy. Surg Oncol. 2009; 16: 1170-1175.
  • 29
    Koelliker SL, Chung MA, Mainiero MB, Steinhoff MM, Cady B. Axillary lymph nodes: US-guided fine-needle aspiration for initial staging of breast cancer- correlation with primary tumor size. Radiology. 2008; 246: 81-89.
  • 30
    Ciatto S, Brancato B, Risso G, et al. Accuracy of fine needle aspiration cytology (FNAC) of axillary lymph nodes as a triage test in breast cancer staging. Breast Cancer Res Treat. 2007; 103: 85-91.
  • 31
    Van Rijk MC, Duerloo EE, Nieweg OE, et al. Ultrasonography and fine-needle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy. Ann Surg Oncol. 2005; 13: 31-35.
  • 32
    Popli MB, Sahoo M, Mehrotra N, et al. Preoperative ultrasound-guided fine-needle aspiration cytology for axillary staging in breast carcinoma. Australas Radiol. 2006; 50: 122-126.
  • 33
    Gilissen F, Oostenbroek R, Storm R, Westenend P, Plaisier P. Prevention of futile sentinel node procedures in breast cancer: ultrasonography of the axilla and fine-needle aspiration cytology are obligatory. Eur J Surg Oncol. 2006; 34: 497-500.
  • 34
    Hinson JL, McGrath P, Moore A, et al. The critical role of axillary ultrasound and aspiration biopsy in the management of breast cancer patients with clinically negative axilla. Ann Surg Oncol. 2007; 15: 250-255.
  • 35
    Sahoo S, Sanders MA, Roland L, et al. A strategic approach to the evaluation of axillary lymph nodes in breast cancer patients: analysis of 168 patients at a single institution. Am J Surg. 2007; 194: 524-526.
  • 36
    Holwitt DM, Swatske ME, Gillanders WE, et al. The combination of axillary ultrasound and ultrasound-guided biopsy is an accurate predictor of axillary lymph nodes as a triage test in breast cancer staging. Breast Cancer Res Treat. 2007; 103: 85-91.
  • 37
    Altomare V, Guerrero G, Carino R, et al. Axillary lymph node echo-guided fine-needle aspiration cytology enables breast cancer patients to avoid a sentinel lymph node biopsy. Preliminary experience and a review of the literature. Surg Today. 2007; 37: 735-739.
  • 38
    Tahir M, Osman KA, Shabbir J, et al. Preoperative axillary staging in breast cancer-saving time and resources. Breast J. 2008; 14: 369-371.
  • 39
    Alkuwari E, Auger M. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation. Cancer. 2008; 114: 89-93.
  • 40
    Krishnamurthy S, Hynek I, Vasquez S, Hunt KK, Yang W. Utility of ultrasound-guided fine needle aspiration of indeterminate and suspicious axillary lymph nodes in the management of patients with early breast cancer: a study of 278 patients. Cancer (Cancer Cyopathol). 2008; 114( S5): 350.
  • 41
    Swinson C, Ravichandran D, Nayagam M, Allen S. Ultrasound and fine needle aspiration cytology of the axilla in the pre-operative identification of axillary nodal involvement in breast cancer. Eur J Surg Oncol. 2009 May 14. [Epub ahead of print].
  • 42
    Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994; 220: 391-401.
  • 43
    Veronesi V, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997; 349: 1864-1867.
  • 44
    Krag D, Weaver D, Ashikaga T, et al. The sentinel lymph node in breast cancer-a multi center validation study. N Engl J Med. 1998; 339: 941-946.
  • 45
    Krag DN, Anderson SJ, Julian TB, et al. Technical outcome of sentinel lymph node resection and conventional axillary lymph node dissection in patients with clinically node negative breast cancer: results from the NSABP B-32 randomized phase III trial. Lancet. 2007; 8: 881-888.
  • 46
    McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2008; 18: 2560-2566.
  • 47
    Albo D, Wayne JD, Hunt KK, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg. 2001; 182: 393-398.
  • 48
    Montgomery LL, Thorne AC, Van Zee KJ, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg. 2002; 95: 385-388.
  • 49
    Fisher B, Brown A, Mamounas et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997; 15: 2483-2493.
  • 50
    Buchholz TA, Hunt KK, Whitman GJ, et al. Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks. Cancer. 2003; 98: 1150-1160.
  • 51
    Khan A, Sabel MS, Nees A, et al. Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy. Ann Surg Oncol. 2005; 12: 697-704.
  • 52
    Oruwari JU, Chung MA, Koelliker S, Steinhoff MM, Cady B. Axillary staging using ultrasound-guided fine needle aspiration biopsy on locally advanced breast cancer. Am J Surg. 2002; 184: 307-309.
  • 53
    Somasundar P, Grass J, Steinhoff M, et al. Role of ultrasound-guided axillary fine-needle aspiration in the management of invasive breast cancer. Am J Surg. 2006; 192: 458-461.
  • 54
    Kilbride KE, Lee MC, Nees AV, et al. Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrence. Am Surg Oncol. 2008; 15: 3252-3258.
  • 55
    Straver ME, Rutgers EJ, Russell NS, et al. Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer. Eur J Cancer. 2009; 45: 2284-2292.
  • 56
    Newman LA, Kuerer HM, Fornage B, et al. Adverse prognostic significance of infraclavicular lymph nodes detected by ultrasonography in patients with locally advanced breast cancer. Am J Surg. 2001; 81: 313-318.
  • 57
    Egan RL, McSweeney MB. Intramammary lymph nodes. Cancer. 1983; 51: 1838-1842.
  • 58
    Jadusingh IH. Intramammary lymph nodes. J Clin Pathol. 1992; 45: 1023-1026.
  • 59
    Hogan BV, Peter MB, Shenoy H, Horgan K, Shaaban A. Intramammary lymph node metastasis predicts poorer survival in breast cancer patients. Surg Oncol. 2009 Jan 24. [Epub ahead of print].
  • 60
    Edeiken-Monroe BS, Monroe DP, Monroe BJ, et al. Metastases to intramammary lymph nodes in patients with breast cancer: sonographic findings. J Clin Ultrasound. 2008; 36: 279-285.
  • 61
    Shen J, Hunt KK, Mirza NQ, et al. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma. Cancer. 2004; 101: 1330-1337.
  • 62
    Nassar A, Cohen C, Cotsonis G, Carlson G. Significance of intramammary lymph nodes in the staging of breast cancer: correlation with tumor characteristics and outcome. Breast J. 2008; 14: 147-152.
  • 63
    Guth AA, Mercado C, Roses DF, et al. Intramammary lymph nodes and breast cancer a marker for disease severity, or just another lymph node? Am J Surg. 2006; 92: 502-505.
  • 64
    Intra M, Garcia-Etienne CA, Renne G, et al. When sentinel lymph node is intramammary. Ann Surg Oncol. 2008; 15: 1304-1308.
  • 65
    Cox CE, Cox JM, Ramos D, Meade TL. Intramammary sentinel lymph nodes: what is the clinical significance. Ann Surg Oncol. 2008; 15: 1273-1274.
  • 66
    Skrabalak SE, Au L, Lu X, Li X, Xia Y. Gold nanocages for cancer detection and treatment. Nanomed. 2007; 2: 657-668.
  • 67
    Pramanik M, Song KM, Swierczewska M, Greer D, Sitharaman B, Wang LV. In vivo carbon nanotube-enhanced non-invasive photoacoustic mapping of the sentinel lymph node. Phys Med Biol. 2009; 54: 3291-3301.
  • 68
    Song KH, Kim C, Cobley CM, Xia Y, Wang LV. Near-infrared gold nanocages as a new class of tracers for photoacoustic sentinel lymph node mapping on a rat model. Nano Lett. 2009; 9: 183-188.
  • 69
    Song KH, Kim C, Maslov K, Wang LV. Noninvasive in vivo spectroscope nanorod-contrast photoacoustic mapping of sentinel lymph nodes. Eur J Radiol. 2009; 70: 227-231.